Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31

Blood

Volumn 95, Issue 7, 2000, Pages 2372-2377

  Horrigan, Stephen K ^b   Arbieva, Zarema H ^b   Xie, Hong Yan ^b   Kravarusic, Jelena ^b   Fulton, Noreen C ^b   Naik, Haley ^b   Le, Tiffany T ^b   Westbrook, Carol A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME 5; CHROMOSOME DELETION; CHROMOSOME LOSS; CONTROLLED STUDY; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MYELODYSPLASIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0034177514     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.7.2372.007k20_2372_2377     Document Type: Article

References (34)

1. Fourth International Workshop on Chromosomes in Leukemia: a prospective study of acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1984;11:249.
2. Van den Berghe H, Vermaelen K, Mecucci C, Barbieri D, Tricot G. The 5q- anomaly. Cancer Genet Cytogenet. 1985;17:189.
3. Nimer SD, Golde DW. The 5q- abnormality. Blood. 1987;70:1705.
4. Boultwood J, Lewis S, Wainscoat JS. The 5q-syndrome. Blood. 1994;84:3253.
5. Pedersen-Bjergaard J, Phillip P, Larsen SO, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood. 1990;76:1083.
6. Le Beau MM, Albain KS, Larson RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no, 5 and 7. J Clin Oncol. 1986;4:325.
7. Larson RA, Le Beau MM, Vardiman JW, Testa JR. Golomb HM, Rowley JD. The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982). Cancer Genet Cytogenet. 1983;10:219.
8. Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood. 1989;73:263.
9. Pedersen B. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment. Anticancer Res. 1993;13:1913.
10. Tefferi A, Mathew P, Noel P. The 5q- syndrome: a scientific and clinical update. Leuk Lymphoma. 1994;14:375.
11. Le Beau MM, Espinosa R III, Neuman WL, et al. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci U S A. 1993;90:5484.
12. Fairman J, Chumakov I, Chinault AC, Nowell PC, Nagarajan L. Physical mapping of the minimal region of loss in 5q chromosome. Proc Natl Acad Sci U S A. 1995;92:7406.
13. Horrigan SK, Westbrook CA, Kim AH, Banerjee M, Stock W, Larson RA. Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood. 1996;88: 2665.
14. Zhao N, Stoffel A, Wang PW, et al. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Proc Natl Acad Sci U S A. 1997;94: 6948.
15. Boultwood J, Fidler C, Lewis S, et al. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint. Genomics. 1994;19: 425.
16. Horrigan SK, Bartoloni L, Speer MC, et al. A radiation hybrid breakpoint map of the acute myeloid leukemia (AML) and Limb-Girdle muscular dystrophy 1A (LGMD1A) regions of chromosome 5q31 localizing 122 expressed sequences. Genomics. 1999;57:24.
17. Gyapay G, Schmitt K, Fizames C, et al. A radiation hybrid map of the human genome. Hum Mol Genet. 1996;5:339.
18. Stewart EA, McKusick KB, Aggarwal A, et al. An STS-based radiation hybrid map of the human genome. Genome Res. 1997;7:422
19. Bruno E, Korrigan SK, Van Den Berg D, et al. The Smad5 gene is involved in the intracellular signaling pathways which mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. Blood. 1998;91:1917.
20. Bartoloni L, Horrigan S, Viles H, et al. Use of a CEPH meiotic breakpoint panel to refine the locus of limb-girdle muscular dystrophy type 1A (LGMD1A) to a 2-Mb interval on 5q31. Genomics. 1998;54:250.
21. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Ann Rev Biochem. 1990;59:237.
22. Shimoyama Y, Hirohashi S. Cadherin intracellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett. 1991;57:131.
23. Vermeulen SJ, Nollet F, Teugels E, et al. The alphaE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells. Oncogene. 1999;18:905.
24. Sadhu K, Reed SI, Richardson H, Russell P. Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc Natl Acad Sci U S A. 1990;87:5139.
25. Nguyen HQ, Hoffman-Liebermann B, Liebermann DA. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell. 1993;72:197.
26. Wadhwa R, Pereira-Smith OM, Reddel RR, Sugimoto Y, Mitsui Y, Kaul SC. Correlation between complementation group for immortality and the cellular distribution of mortalin. Exp Cell Res. 1995;216:101.
27. Monden T, Wondisford FE, Hollenberg AN. Isolation and characterization of a novel ligand-dependent thyroid hormone receptor-coactivating protein. J Biol Chem. 1997;272:29,834.
28. Zhao N, Lai F, Fernald AA, et al. Human CDC23: cDNA cloning, mapping to 5q31, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias. Genomics. 1998;53:184.
29. Sardella M, Navone F, Rocchi M, et al. KIF3C, a novel member of the kinesin superfamily: sequence, expression, and mapping to human chromosome 2 at 2p23. Genomics. 1998;47:405.
30. Gallagher R, Collins S, Trujillo J, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 1979;54:713.
31. Koeffler HP, Golde DW. Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 1978;200:1153.
32. Lange B, Valtieri M, Santoli D, et al. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines Blood. 1987;70:192.
33. Furley AJ, Reeves BR, Mizutani S, et al. Divergent molecular phenotypes of KG-1 and KG1a myeloid cell lines. Blood. 1986;68:1101.
34. Deloukas P, Schuler GB, Cyapay G, et al. A physical map of 30,000 human genes. Science. 1998;282:744.